Humacyte, Inc.HUMANASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -21.51% |
| Q2 2025 | 42.73% |
| Q1 2025 | -25.36% |
| Q4 2024 | -9.90% |
| Q3 2024 | -3.48% |
| Q2 2024 | 11.71% |
| Q1 2024 | 5.37% |
| Q4 2023 | 8.78% |
| Q3 2023 | -9.68% |
| Q2 2023 | 18.88% |
| Q1 2023 | 15.52% |
| Q4 2022 | -13.73% |
| Q3 2022 | 18.33% |
| Q2 2022 | -10.19% |
| Q1 2022 | 0.39% |
| Q4 2021 | 5.62% |
| Q3 2021 | 5.62% |
| Q2 2021 | -3.76% |
| Q1 2021 | 14.68% |
| Q4 2020 | -10.16% |
| Q3 2020 | 24.27% |
| Q2 2020 | -17.69% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |